RCB
Asset Logo

Russell Investments Australian Select Corporate Bond Etf

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

📙 Holdings

💰 Distributions

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual growth

💰

0.55%
Annual distribution yield

Based on the most recent distribution

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

3
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

RCB.AX was created on 2012-03-08 by Russell. The fund's investment portfolio concentrates primarily on investment grade fixed income. The Fund aims to provide a total return before costs and tax, in line with DBIQ 0-4 year Investment Grade Australian Corporate Bond Index over the long term

🌐 Website

📈 Performance

Price History

-2.25%

1M

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

📙 Top Holdings

Show more
Commonwealth Bank of Australia 4.4%
14.13%
Anz Group Hldgs Ltd 4.05%
12.80%
National Australia Bank Ltd. 2.9%
12.32%
Westpac Banking Corp. 4.125%
10.12%
Anz Group Hldgs Ltd 1.55%
8.10%
National Australia Bank Ltd. 1.65%
7.95%
Westpac Banking Corp. 2.4%
7.23%
Westpac Banking Corp. 2.25%
6.49%
Westpac Banking Corp. 2.7%
5.81%
Anz Group Hldgs Ltd 1.65%
4.27%

Updated as of 18 May 2023

Country Exposure
🇦🇺 Australia
100%

💰 Distributions

Payouts

💰 Annual Distribution Yield*

0.55%

💰 Annual Distribution Earnings Per $1,000 invested**

$5.52

💰 Most Recent Distribution Franked Percentage Estimate

0.00%

💰 Average Distribution Franked Percentage Estimate

0.00 %

💰 Distribution reinvestment

Learn more

* Based on the most recent distribution

** Calculated by multiplying the most recent distribution yield by $1,000

Distribution History

1Y

5Y

10Y

Graph

Table

Year
Yearly Distribution Earnings Per Share
Franking Estimate

2024

$0.00

0.00%

2023

$0.00

0.00%

2022

$0.11

0.00%

2021

$0.32

0.00%

2020

$0.85

0.00%

2019

$0.84

0.00%

2018

$0.63

0.00%

2017

$0.85

0.00%

2016

$0.67

0.00%

2015

$0.83

0.00%

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0.28%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$19.57

💰 Price To Earnings Ratio

0.00

💰 Price To Book Ratio

0.00

💰 Leveraged

No

💰 Inverse

No

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in RCB

3

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in RCB

497 days
RCB investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

20%

50k - 100k

40%

Less than 50k

20%
👶 Age of investors

18 - 25

26 - 34

33%

35 - 90

67%
🙋 Legal gender of investors

Female

67%

Male

33%

Pearlers who invest in RCB also invest in...

iShares Europe Etf

IEU

IEU.AX was created on 2000-07-25 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to provide investors with the performance of the S&P Europe 350TM Index, before fees and expenses. The index is designed to measure the performance of large capitalisation equities and covers 16 major developed European markets

📊 Share price

$77.54 AUD

NULL EX AUSTRALIA

NULL EUROPE

NULL BETA

Find Out More

IAA.AX was created on 2007-11-13 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to provide investors with the performance of the S&P Asia 50TM Index, before fees and expenses. The index is designed to measure the performance of the 50 leading companies listed in China, Hong Kong, Macau, Singapore, South Korea and Taiwan.

📊 Share price

$90.54 AUD

NULL CHINA

NULL OTHER

NULL ASIA

NULL EX AUSTRALIA

NULL BETA

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

📊 Share price

$43.11 AUD

NULL US

NULL EX AUSTRALIA

NULL BETA

IAF.AX was created on 2012-03-12 by iShares. The fund's investment portfolio concentrates primarily on investment grade fixed income. The fund aims to provide investors with the performance of the Bloomberg AusBond Composite 0+ Yr IndexSM, before fees and expenses. The index is designed to measure the performance of the Australian bond market and includes investment grade fixed income securities issued by the Australian Treasury,

📊 Share price

$101.00 AUD

NULL AUSTRALIA

NULL INCOME

AAA.AX was created on 2012-03-06 by BetaShares. The fund's investment portfolio concentrates primarily on target outcome asset allocation. The Fund aims to provide exposure to Australian cash, with attractive and regular incomedistributions that exceed the 30 day Bank Bill Swap Rate (after fees and expenses).

📊 Share price

$50.23 AUD

NULL AUSTRALIA

NULL INCOME

Want more shares? Try these...

Recce Pharmaceuticals Ltd. is engaged in the research and development of pharmaceutical drugs that kill germs. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-01-15. The Company’s anti-infective pipeline includes three broad-spectrum, synthetic polymer anti-infectives: RECCE 327 as an intravenous and topical therapy that is being developed for the treatment of serious and potentially life-threatening infections due to Gram-positive and Gram-negative bacteria including their superbug forms; RECCE 435 as an orally administered therapy for bacterial infections; and RECCE 529 for viral infections. Through their multi-layered mechanisms of action, the Company’s anti-infectives have the potential to overcome the hypercellular mutation of bacteria and viruses. All RECCE compounds are 100% water soluble at all pH levels in their liquid form.

📊 Share price

$0.57 AUD

ReadCloud Ltd. engages in the provision of digital eLearning solutions to Australian secondary schools. The company is headquartered in Melbourne, Victoria and currently employs 500 full-time employees. The company went IPO on 2018-02-07. The firm's eBook reader delivers digital content to students and teachers with functionality, including the ability to make commentary in, and import third party content into eBooks. Students and teachers can share notes, questions, videos and weblinks directly inside the eBooks turning the eBook into a place for discussion, collaboration, and social learning. The company sources content for its solutions from multiple publishers, delivering the full Australian school curriculum in digital form in all States, on one platform. The company also provides digital vocational education and training (VET) course materials and services to schools through its subsidiaries, Australian Institute of Education and Training Unit Trust (AIET), PKY Media Pty Ltd and Ripponlea Institute Pty Ltd, which collectively offers over 60 VET courses and Auspicing services to schools across Australia.

📊 Share price

$0.06 AUD

📊 Share price

$0.00 AUD

RCAP

RCAP.AX was created on 2022-02-22 by Resolution Capital. The fund's investment portfolio concentrates primarily on real estate equity. The Fund aims to achieve an annual total return that exceeds the total return of the Benchmark after fees on a rolling 3 year basis

📊 Share price

$1.48 AUD
Compare
Add to watchlist